Breast Cancer Liquid Biopsy Market, estimated at around USD 330.8 million in 2024, is projected to expand at a robust compound annual growth rate (CAGR) of over 21%, driven by the rising incidence of breast cancer globally and increasing adoption of non-invasive diagnostics using circulating tumor DNA (ctDNA) and other biomarkers. To delve deeper into this research, kindly...